Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Susan Desmond-Hellmann Elected as HHMI Trustee

Published: Thursday, November 08, 2012
Last Updated: Thursday, November 08, 2012
Bookmark and Share
Desmond-Hellmann becomes one of 11 Trustees of the Institute.

Susan D. Desmond-Hellmann, M.D., M.P.H., chancellor of the University of California, San Francisco (UCSF), has been elected a Trustee of the Howard Hughes Medical Institute.

She becomes one of 11 Trustees of the Institute, a medical research organization dedicated to the discovery and dissemination of new knowledge in the life sciences.

Desmond-Hellmann, 55, became chancellor of UCSF in 2009. She is also the Arthur and Toni Rembe Rock Distinguished Professor at UCSF.

An oncologist and renowned biotechnology leader, she spent 14 years at Genentech, serving as president of product development from 2004 to 2009.

In that role, she was responsible for Genentech’s pre-clinical and clinical development, process research and development, business development, and product portfolio management.

During her tenure, Desmond-Hellmann led efforts to bring a number of breakthrough cancer medicines, including Herceptin for breast cancer, to the marketplace.

Prior to joining Genentech, she was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute, where she was the project team leader for the cancer-fighting drug Taxol.

Desmond-Hellmann is board-certified in internal medicine and medical oncology. She holds a B.S. in pre-medicine and a medical degree from the University of Nevada, Reno, and a master’s degree in public health from the University of California, Berkeley.

She completed her clinical training at UCSF, where she has served as associate adjunct professor of epidemiology and biostatistics. She also spent two years studying HIV and cancer at the Uganda Cancer Institute.

Desmond-Hellmann is a member of the American Academy of Arts and Sciences and the Institute of Medicine. She was named Woman of the Year in 2006 by the Healthcare Businesswomen’s Association and inducted into the Biotech Hall of Fame in 2007.

In 2009, Forbes magazine named Desmond-Hellman one of the world’s seven most powerful innovators. She was one of Fortune magazine’s “50 most powerful women in business” in 2001 and from 2003 to 2008.

In December 2010, Desmond-Hellmann was appointed to the Board of Procter & Gamble. In January 2009, she joined the Federal Reserve Bank of San Francisco’s Economic Advisory Council for a three-year term.

In July 2008, she was appointed to the California Academy of Sciences board of trustees and, in 2012, to the Albert and Mary Lasker Foundation's board of directors.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

One-Drop-of-Blood Reveals a Patient’s Viral History
New technology developed by Howard Hughes Medical Institute researchers makes it possible to test for current and past infections with any known human virus by analyzing a single drop of a person's blood.
Tuesday, June 09, 2015
A Crisper View of DNA-Snipping Enzyme
HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
Saturday, February 08, 2014
Spontaneous Mutations Play a Key Role in Congenital Heart Disease
New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Monday, May 13, 2013
A New View of Transcription Initiation
Reading the human genome.
Monday, March 04, 2013
Stash of Stem Cells Found in a Human Parasite
New findings were published online on February 20, 2013, in the journal Nature.
Tuesday, February 26, 2013
Search for Epigenetic Decoder in Brain Cells Leads Scientists to Rett Syndrome
New analysis suggests that MeCP2 recognizes 5hmC in the brain and facilitates activation of the genes.
Monday, December 31, 2012
Scientists Find Mechanism that Triggers Immune Responses to DNA
HHMI scientists have discovered the molecular pathway outside a cell’s nucleus in the cytosol.
Monday, December 24, 2012
Erin O’Shea Named Vice President and Chief Scientific Officer at HHMI
O’Shea to begin her new duties part-time in January 2013 and transition to full-time in July 2013.
Monday, December 03, 2012
HHMI’s Robert Lefkowitz Awarded 2012 Nobel Prize in Chemistry
Robert Lefkowitz and Brian K. Kobilka are the recipients of the 2012 Nobel Prize in Chemistry for studies of G-protein coupled receptors.
Thursday, October 11, 2012
Analysis of Stickleback Genome Sequence Catches Evolution in Action
Reuse of key genes is a common theme, as reported by scientists at the Howard Hughes Medical Institute.
Thursday, April 05, 2012
Autism Gene Screen Highlights Protein Network for Howard Hughes Medical Institute Scientists
Over the past decade, scientists have added many gene mutations to the list of potential risk factors for autism spectrum disorders -- but researchers still lack a definitive explanation of autism’s cause.
Thursday, April 05, 2012
Scientists Trace Origin of Recent Cholera Epidemic in Haiti
The finding supports the notion that the cholera bacteria fueling the outbreak arrived on the island via recent visitors.
Friday, December 10, 2010
Protein-Folding Game Taps Power of Worldwide Audience to Solve Difficult Puzzles
Extended efforts could pay off in the design of new proteins that help fight disease, sequester carbon, or clean up the environment.
Monday, August 09, 2010
New Tool Illuminates Connections Between Stem Cells and Cancer
HHMI researchers have a new tool to understand how cancers grow - and with it a new opportunity to identify novel cancer drugs.
Monday, February 22, 2010
Crash-Test Reveals DNA Traffic Control
Researchers have discovered that when DNA-copying enzymes run head-on into oncoming traffic, they kick the obstacles out of their way.
Friday, January 29, 2010
Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
A New Way Out for Stem Cells
Researchers at North Carolina State University have discovered that therapeutic stem cells exit the bloodstream in a different manner than was previously thought.
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
Designing Potential AIDS Vaccine Candidates
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Anticancer Drug Stops Ebola Virus Molecule in its Tracks
A team of scientists from the University of Oxford have successfully mapped the structure of the Ebola virus molecule that drives the attack strategy and leads to fatal infections in humans.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!